NSN 6505-01-227-3570 · NIIN 012273570 · FSC 6505
NO DASHES 6505012273570
In Stock
CEFTAZIDIME FOR INJECTION
Drugs and Biologicals
Technical characteristics
10 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT 1.000 |
| CBBL | FEATURES PROVIDED | STERILE |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | GRAMS OF ACTIVE INGREDIENT 1.000 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CSGS | ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME FOR INJECTION 1GM VIAL 25S |
| FEAT | SPECIAL FEATURES | EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME. STORE AT 20-25 DEG C (68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
Cross-references
4 manufacturer part numbers on file for this NSN — each shown against the CAGE code it belongs to.
| Manufacturer part number | CAGE |
|---|---|
| NDC00409-5082-16 | 3VBU6 |
| TAZICEF | 3VBU6 |
| NDC25021-0127-20 | 4RP13 |
| NDC44567-0235-25 | 6XJQ8 |